A new addition to Legacy Medical Consultants' innovative
line of wound care products
FORT
WORTH, Texas, April 19,
2024 /PRNewswire/ -- Legacy Medical Consultants
(LMC) announces its newest product portfolio addition with the
recent Q code approval for Reeva FT™, a terminally sterilized,
full-thickness, dual-layered amnion/chorion allograft designed
for covering and protection during advanced wound
treatment.
"There is a critical need in the wound care space for these
advanced allograft products," says Jonathan
Knutz, CEO of Legacy Medical Consultants, "and we continue
to deliver solutions that innovate while advancing a
well-established and proven medical technology."
About Reeva FT
Reeva FT is a lyophilized human placental-based allograft
consisting of amnion and chorion membranes, with the retention of
the intermediate layer. Reeva FT provides a protective covering to
the surrounding environment in acute and chronic wounds. The graft
also introduces a naturally derived extracellular matrix that acts
as a scaffold to support native tissue during treatment. Reeva FT
hydrostatically adheres to wounds and has a 5-year shelf life when
stored at ambient temperature.
Reeva FT is offered in a variety of sizes: 2x2 cm, 2x3 cm, 4x4
cm, 4x6 cm, 4x8 cm, and 10x15 cm. Reeva FT is confirmed by the FDA
Tissue Reference Group to meet the criteria for regulation solely
under Section 361 of the PHS Act as defined in 21 CFR Part
1271.
In the most recent HCPCS announcement by CMS, Reeva FT was
assigned a new HCPCS Level II code of Q4314.
About Legacy Medical Consultants
Legacy Medical Consultants elevates patient care by addressing
unmet clinical needs in wound patients. Legacy Medical Consultants'
team of dedicated professionals serves both providers and their
patients in the field of complex wound care. To learn more about
LMC's portfolio of products please
visit https://www.legacymedicalconsultants.com/.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/legacy-medical-consultants-announces-reeva-ft-a-full-thickness-allograft-for-wound-covering-and-protection-during-treatment-302121567.html
SOURCE Legacy Medical Consultants